CSL / WORLD—01CYTOSOMATIC LABS

GLOBAL RESEARCH PARTICIPATION

Global Research Hub

Discover recruiting neuroscience, neuroimmune, regenerative medicine and related research opportunities worldwide.

Registry results
4780
Studies displayed
30
Listed institutions
1481
Last checked · UTC
2026-11-17 20:08
Fiji · 0 displayed studiesTanzania · 0 displayed studiesW. Sahara · 0 displayed studiesCanada · 8 displayed studiesUnited States of America · 20 displayed studiesKazakhstan · 0 displayed studiesUzbekistan · 0 displayed studiesPapua New Guinea · 0 displayed studiesIndonesia · 0 displayed studiesArgentina · 6 displayed studiesChile · 4 displayed studiesDem. Rep. Congo · 0 displayed studiesSomalia · 0 displayed studiesKenya · 0 displayed studiesSudan · 0 displayed studiesChad · 0 displayed studiesHaiti · 0 displayed studiesDominican Rep. · 0 displayed studiesRussia · 0 displayed studiesBahamas · 0 displayed studiesFalkland Is. · 0 displayed studiesNorway · 2 displayed studiesGreenland · 0 displayed studiesFr. S. Antarctic Lands · 0 displayed studiesTimor-Leste · 0 displayed studiesSouth Africa · 2 displayed studiesLesotho · 0 displayed studiesMexico · 2 displayed studiesUruguay · 0 displayed studiesBrazil · 6 displayed studiesBolivia · 0 displayed studiesPeru · 3 displayed studiesColombia · 3 displayed studiesPanama · 0 displayed studiesCosta Rica · 0 displayed studiesNicaragua · 0 displayed studiesHonduras · 0 displayed studiesEl Salvador · 0 displayed studiesGuatemala · 1 displayed studiesBelize · 0 displayed studiesVenezuela · 0 displayed studiesGuyana · 0 displayed studiesSuriname · 0 displayed studiesFrance · 7 displayed studiesEcuador · 0 displayed studiesPuerto Rico · 3 displayed studiesJamaica · 0 displayed studiesCuba · 0 displayed studiesZimbabwe · 0 displayed studiesBotswana · 0 displayed studiesNamibia · 0 displayed studiesSenegal · 0 displayed studiesMali · 0 displayed studiesMauritania · 0 displayed studiesBenin · 0 displayed studiesNiger · 0 displayed studiesNigeria · 0 displayed studiesCameroon · 0 displayed studiesTogo · 0 displayed studiesGhana · 0 displayed studiesCôte d'Ivoire · 0 displayed studiesGuinea · 0 displayed studiesGuinea-Bissau · 0 displayed studiesLiberia · 0 displayed studiesSierra Leone · 0 displayed studiesBurkina Faso · 0 displayed studiesCentral African Rep. · 0 displayed studiesCongo · 0 displayed studiesGabon · 0 displayed studiesEq. Guinea · 0 displayed studiesZambia · 0 displayed studiesMalawi · 0 displayed studiesMozambique · 0 displayed studieseSwatini · 0 displayed studiesAngola · 0 displayed studiesBurundi · 0 displayed studiesIsrael · 3 displayed studiesLebanon · 0 displayed studiesMadagascar · 0 displayed studiesPalestine · 0 displayed studiesGambia · 0 displayed studiesTunisia · 0 displayed studiesAlgeria · 0 displayed studiesJordan · 0 displayed studiesUnited Arab Emirates · 0 displayed studiesQatar · 0 displayed studiesKuwait · 0 displayed studiesIraq · 0 displayed studiesOman · 0 displayed studiesVanuatu · 0 displayed studiesCambodia · 0 displayed studiesThailand · 3 displayed studiesLaos · 0 displayed studiesMyanmar · 0 displayed studiesVietnam · 1 displayed studiesNorth Korea · 0 displayed studiesSouth Korea · 5 displayed studiesMongolia · 0 displayed studiesIndia · 3 displayed studiesBangladesh · 0 displayed studiesBhutan · 0 displayed studiesNepal · 0 displayed studiesPakistan · 0 displayed studiesAfghanistan · 0 displayed studiesTajikistan · 0 displayed studiesKyrgyzstan · 0 displayed studiesTurkmenistan · 0 displayed studiesIran · 0 displayed studiesSyria · 0 displayed studiesArmenia · 0 displayed studiesSweden · 3 displayed studiesBelarus · 0 displayed studiesUkraine · 2 displayed studiesPoland · 6 displayed studiesAustria · 1 displayed studiesHungary · 5 displayed studiesMoldova · 0 displayed studiesRomania · 5 displayed studiesLithuania · 0 displayed studiesLatvia · 0 displayed studiesEstonia · 0 displayed studiesGermany · 9 displayed studiesBulgaria · 1 displayed studiesGreece · 6 displayed studiesTurkey · 0 displayed studiesAlbania · 0 displayed studiesCroatia · 1 displayed studiesSwitzerland · 1 displayed studiesLuxembourg · 0 displayed studiesBelgium · 5 displayed studiesNetherlands · 4 displayed studiesPortugal · 2 displayed studiesSpain · 9 displayed studiesIreland · 1 displayed studiesNew Caledonia · 0 displayed studiesSolomon Is. · 0 displayed studiesNew Zealand · 2 displayed studiesAustralia · 7 displayed studiesSri Lanka · 0 displayed studiesChina · 8 displayed studiesTaiwan · 4 displayed studiesItaly · 9 displayed studiesDenmark · 2 displayed studiesUnited Kingdom · 9 displayed studiesIceland · 0 displayed studiesAzerbaijan · 0 displayed studiesGeorgia · 1 displayed studiesPhilippines · 2 displayed studiesMalaysia · 2 displayed studiesBrunei · 0 displayed studiesSlovenia · 0 displayed studiesFinland · 4 displayed studiesSlovakia · 0 displayed studiesCzechia · 5 displayed studiesEritrea · 0 displayed studiesJapan · 6 displayed studiesParaguay · 0 displayed studiesYemen · 0 displayed studiesSaudi Arabia · 1 displayed studiesAntarctica · 0 displayed studiesN. Cyprus · 0 displayed studiesCyprus · 0 displayed studiesMorocco · 0 displayed studiesEgypt · 0 displayed studiesLibya · 0 displayed studiesEthiopia · 0 displayed studiesDjibouti · 0 displayed studiesSomaliland · 0 displayed studiesUganda · 0 displayed studiesRwanda · 0 displayed studiesBosnia and Herz. · 0 displayed studiesMacedonia · 0 displayed studiesSerbia · 1 displayed studiesMontenegro · 0 displayed studiesKosovo · 0 displayed studiesTrinidad and Tobago · 0 displayed studiesS. Sudan · 0 displayed studies

Map scope: displayed ClinicalTrials.gov records only. Not worldwide totals.

No displayed recordsLow · 1–2Medium · 3–7High · 8–15Very high · 16+

RECRUITING NOW

Concurrent Research

My Research Opportunities

ClinicalTrials.gov · External studies

NCT05824169Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

Spinal Muscular Atrophy

PHASE1 · PHASE2 / China / 2026-11-17

ClinicalTrials.gov
NCT07943442Recruiting

Novel MRI for an Earlier Diagnosis of Motor Neurone Disease

Motor Neurone Disease (MND) · Health Adult Subjects

United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT06841354Recruiting

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Triple Negative Breast Neoplasms

PHASE3 / United States · Argentina · Australia · Belgium · Brazil · Canada · Chile · China · Colombia · Czechia · Denmark · Finland · France · Germany · Greece · Hong Kong · Hungary · Israel · Italy · Japan · Malaysia · Mexico · Netherlands · New Zealand · Peru · Philippines · Poland · Romania · South Korea · Spain · Taiwan · Thailand · Turkey (Türkiye) · Ukraine · United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT07176286Recruiting

18F-mFBG Cardiac Uptake With Lewy Body Dementia

Parkinson Disease (PD) · Lewy Body Dementia (LBD)

PHASE2 / United States / 2026-11-17

ClinicalTrials.gov
NCT07758114Recruiting

Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS)

Environmental Exposure · Pregnancy Related · Preterm Birth · Chronic Respiratory Disease · Neurodegenerative Diseases

NA / United States / 2026-11-17

ClinicalTrials.gov
NCT05683418Recruiting

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

HR+/HER2-negative Breast Cancer

PHASE1 / United States · Spain / 2026-11-17

ClinicalTrials.gov
NCT02446262Recruiting

Neural and Psychological Mechanisms of Pain Perception

Pain · Normal Physiology · Healthy Volunteers

NA / United States / 2026-11-17

ClinicalTrials.gov
NCT07721025Recruiting

Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy

Friedreich Ataxia · Cardiomyopathy, Secondary

PHASE2 / United States · Brazil · Canada · Czechia · France · Germany · Italy · Spain · United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT07943702Recruiting

Correlation Between Visual Reading and DOlab Software Quantitative Analysis of DaT-SPECT Images

Parkinsonian Disorders · Parkinson Disease · Lewy Body Disease · Movement Disorders

Italy / 2026-11-17

ClinicalTrials.gov
NCT06014424Recruiting

Cannabidiol Medication Intervention Trial

Alzheimer Disease

PHASE2 / Canada / 2026-11-17

ClinicalTrials.gov
NCT07430956Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

Atrial Fibrillation (AF)

PHASE3 / United States · Canada / 2026-11-17

ClinicalTrials.gov
NCT06976216Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Alzheimer's Disease

PHASE3 / United States · Argentina · Australia · Brazil · Canada · Chile · Croatia · Czechia · France · Germany · Greece · India · Italy · Netherlands · Poland · Puerto Rico · Romania · South Korea · Spain / 2026-11-17

ClinicalTrials.gov
NCT06952504Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Endometrial Cancer

PHASE3 / United States · Argentina · Australia · Austria · Belgium · Brazil · Canada · Chile · China · Colombia · Czechia · Denmark · Finland · France · Germany · Greece · Hungary · Ireland · Israel · Italy · Japan · Mexico · Netherlands · Norway · Peru · Poland · Puerto Rico · Singapore · South Korea · Spain · Sweden · Taiwan · Thailand · United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT07169630Recruiting

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

Alzheimer s Disease · Mild Cognitive Impairment · Healthy

PHASE1 / United States / 2026-11-17

ClinicalTrials.gov
NCT07173933Recruiting

Evaluation of the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)

Wilson Disease

PHASE1 · PHASE2 / China / 2026-11-17

ClinicalTrials.gov
NCT07932080Recruiting

Evaluation of the Predictive Value of Microemboli Detected by Robotic Transcranial Doppler (TCD) for the Occurrence of an Acute Ischemic Stroke (AIS) or Left Ventricular Thrombus (LVT) in ST Elevation Myocardial Infarction (STEMI) Patients With Left Ventricular Dysfunction (LVD).

STEMI · Left Ventricular Thrombus · Acute Ischemic Stroke

NA / Belgium / 2026-11-17

ClinicalTrials.gov
NCT06463587Recruiting

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Generalized Myasthenia Gravis

PHASE3 / United States · Argentina · Australia · Belgium · Bulgaria · Canada · China · France · Georgia · Germany · Greece · Hungary · India · Italy · Japan · Poland · Romania · Serbia · South Africa · South Korea · Spain · Sweden · Switzerland · Taiwan · Turkey (Türkiye) · United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT07787182Recruiting

A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

Healthy Volunteers · Alzheimer Disease · Amyloid · Plaque, Amyloid

PHASE1 / United States · China · Japan / 2026-11-17

ClinicalTrials.gov
NCT07723976Recruiting

A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE

Developmental and Epileptic Encephalopathy (DEE)

PHASE3 / United States · Australia · Hungary · Italy · Spain / 2026-11-17

ClinicalTrials.gov
NCT04550728Recruiting

Hybrid Robot+FES Stroke Rehabilitation

Stroke

PHASE1 · PHASE2 / United States / 2026-11-17

ClinicalTrials.gov
NCT06976203Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Alzheimer's Disease

PHASE3 / United States · Argentina · Australia · Brazil · Finland · France · Germany · Greece · Italy · Japan · Netherlands · Poland · Portugal · Puerto Rico · Romania · Spain · United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT01273129Recruiting

Surgery as a Treatment for Medically Intractable Epilepsy

Epilepsy · Epilepsy, Temporal Lobe · Partial Epilepsy

United States / 2026-11-17

ClinicalTrials.gov
NCT07099053Recruiting

PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)

Aging

United States / 2026-11-17

ClinicalTrials.gov
NCT06966700Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms

PHASE3 / United States · Argentina · Australia · Belgium · Brazil · Canada · Chile · China · Colombia · Czechia · Finland · France · Germany · Greece · Guatemala · Hong Kong · Hungary · India · Israel · Italy · Japan · Malaysia · New Zealand · Norway · Peru · Philippines · Poland · Portugal · Romania · Saudi Arabia · Singapore · South Africa · South Korea · Spain · Sweden · Taiwan · Thailand · Turkey (Türkiye) · Ukraine · United Kingdom · Vietnam / 2026-11-17

ClinicalTrials.gov
NCT07740707Recruiting

Short-term SCS for Refractory Diabetic Foot Neuropathic Pain

Refractory Diabetic Foot Neuropathic Pain

NA / China / 2026-11-17

ClinicalTrials.gov
NCT04263285Recruiting

Treatment of Depression Post-SCI

Depression · Spinal Cord Injuries

NA / United States / 2026-11-17

ClinicalTrials.gov
NCT07553650Recruiting

Master Study Protocol for the Cohort of the Specialty Network Stroke (SN Stroke)(Stroke-CORE)

Intracerebral Haemorrhage · Paediatric Stroke · Stroke Acute · Stroke · Ischemic Stroke

Germany / 2026-11-17

ClinicalTrials.gov
NCT06553625Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Parkinson Disease · Dystonia · Essential Tremor · Movement Disorders

Germany · United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT07943065Recruiting

A Feasibility Study of a Wearable Arrhythmia Monitoring System (PulseON) in Stroke Patients

Cryptogenic Stroke · Atrial Fibrillation (Prevention of Stroke)

United Kingdom / 2026-11-17

ClinicalTrials.gov
NCT07778836Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia

Friedreich Ataxia · Friedreich's Ataxia

PHASE3 / United States / 2026-11-17

ClinicalTrials.gov

PROVENANCE / SOURCE NETWORK

Original sources. Always.

Only ClinicalTrials.gov supplies this live feed. Other registries are direct source links, not connected feeds. Recruitment must be confirmed with each study team.